Grifols, S.A.：市場シェア分析...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
3 Definitions of Markets/Categories Covered 8
3.1 In Vitro Diagnostics 8
3.1.1 Haematology 8
4 Company Snapshot 9
4.1 Key Facts 9
4.2 Company Overview 9
4.3 Financial Performance 9
4.4 SWOT Snapshot 10
4.5 Business Overview 10
4.6 Major Products and Services 11
4.6.1 Overview 11
5 History 13
6 SWOT Analysis 17
6.1 Overview 17
6.2 Grifols, S.A. Strengths 17
6.2.1 Focused Research and Development 17
6.2.2 Diverse Product and Service Portfolio 18
6.2.3 Wide Geographic Presence 18
6.2.4 Robust Manufacturing Base 19
6.3 Grifols, S.A. Weaknesses 19
6.3.1 Operational Inefficiency 19
6.4 Grifols, S.A. Opportunities 19
6.4.1 Growth in Emerging Economies 19
6.4.2 Inorganic Growth Strategies 20
6.4.3 Potential Life sciences Market 20
6.5 Grifols, S.A. Threats 20
6.5.1 Rapid Technological Change 20
6.5.2 Stringent Government Regulations 20
6.5.3 Changing Diagnostic Market Conditions 21
6.5.4 Cost Containment Pressures 21
7 Competitors 22
8 Competitive Landscape 23
8.1 In Vitro Diagnostics (Haematology), Global, Market Share (%), 2011 23
8.2 Grifols, S.A., In Vitro Diagnostics (Haematology), by Region, Market Share (2011) 25
8.3 Grifols, S.A., In Vitro Diagnostics (Haematology), by Country, Market Share (2011) 26
9 Key Employees 28
10 Locations And Subsidiaries 29
10.1 Head Office 29
10.2 Other Locations & Subsidiaries 30
11 Financial Deals Landscape 32
11.1 Grifols, S.A., Deals Volume Summary, 2007 to YTD 2012 32
12 Grifols, S.A. Detailed Deal Summary 34
12.1 Venture Financing 34
12.1.1 Cardio3 BioSciences Secures $9.56 Million In Series B Financing 34
12.2 Partnerships 35
12.2.1 Grifols Enters Into Distribution Agreement With Kainos Labs 35
12.2.2 Health Robotics Enters Into Co-Marketing Agreement With Grifols 36
12.2.3 Grifols Enters Into Co-Marketing Agreement With Novartis 37
12.2.4 Progenika Biopharma Enters Into An Agreement With Grifols 38
12.2.5 AMDL Diagnostics Enters Into Distribution Agreement With Grifols 39
12.2.6 Accumetrics Enters Into Agreement With Grifols 40
12.2.7 Cerus Enters Into An Agreement With Grifols 41
12.2.8 Grifols Enters Into Agreement With Gambro 42
12.2.9 Transasia Bio-Medicals Enters Into Agreement With Grifols 43
12.2.10 Grifols Signs An Agreement With Cerus 44
12.2.11 Grifols Completes Private Placement Of Bonds For $600 Million 45
12.3 Acquisition 46
12.3.1 Grifols Acquires Remaining 51% Stake In Lateral-Medion 46
12.3.2 Grifols Acquires Medion Diagnostics 47
12.3.3 Grifols Acquires Minority Stake In Cardio3 BioSciences 48
13 Recent Developments 49
13.1 Strategy And Business Planning 49
13.1.1 Apr 19, 2012: Grifols Opens New Plasma Testing Laboratory In San Marcos 49
13.1.2 Aug 02, 2011: Grifols Announces New North American Commercial Operations Organization 49
13.1.3 Jun 15, 2011: Grifols Inaugurates Global Headquarters In Barcelona 50
13.1.4 Mar 04, 2011: Grifols Establishes Expert Advisory Council In Transfusion Medicine 50
13.1.5 Feb 18, 2011: Grifols To Construct New Plasma Fractionation Plant In Barcelona, Spain 51
13.1.6 Sep 02, 2009: Accumetrics Signs Partnership Agreement With Grifols 51
13.2 Financial Announcements 52
13.2.1 Jul 31, 2012: Grifols Reports Revenue Of €650m In Q2 2012 52
13.2.2 Apr 24, 2012: Grifols Reports Revenue Of €666.7m In Q1 2012 52
13.2.3 Feb 28, 2012: Grifols Reports Revenue Of €1.8 Billion In 2011 52
13.2.4 Nov 15, 2011: Grifols Reports Revenue Of €1.2 Billion For Nine Months Ended September 30, 2011 53
13.2.5 Jul 28, 2011: Grifols Reports Revenue Of €635.3m In H1 2011 53
13.2.6 May 05, 2011: Grifols Reports Revenue Of €261.4m In Q1 2011 53
13.2.7 Apr 07, 2011: Grifols Reports Revenue Of €990.7m In 2010 54
13.2.8 Apr 28, 2010: Grifols Reports Net Profit Of EUR36.5 Million In Q1 2010 54
13.2.9 Feb 25, 2010: Grifols Reports Net Profit Of EUR148 Million In 2009 55
13.2.10 Jul 29, 2009: Grifols Reports Net Profit Of EUR40.1 Million In Q2 2009 56
13.2.11 Apr 28, 2009: Grifols Reports Increase In Net Profit By 33.8% For Q1 2009 56
13.2.12 Feb 26, 2009: Grifols Reports Net Profit Of EUR121.7 Million For Full Year 2008 57
13.2.13 Oct 30, 2008: Grifols Reports Net Profit Of EUR92.8 Million For Nine Months Of 2008 58
13.2.14 Aug 27, 2008: Grifols Declares H1 2008 Results 59
13.2.15 May 14, 2008: Grifols Declares Q1 2008 Results 61
13.2.16 Feb 28, 2008: Grifols Declares 2007 Results 62
13.2.17 Nov 08, 2007: Grifols Declares Nine Months Ended 2007 Results 63
13.2.18 Aug 29, 2007: Grifols Declares H1 2007 Results 64
13.2.19 May 10, 2007: Grifols Declares Q1 2007 Results 65
13.2.20 Feb 26, 2007: Grifols Declares 2006 Results 66
13.3 Research And Development 68
13.3.1 Jun 02, 2009: Cerus, Grifols Collaborate For Red Blood Cell Treatment 68
13.4 Corporate Communications 68
13.4.1 Jun 06, 2011: Grifols Establishes New Board Of Directors For US Operations 68
13.4.2 Dec 11, 2008: Grifols Appoints Anna Veiga As Independent Director 69
13.5 Government and Public Interest 70
13.5.1 May 02, 2011: Grifols And Talecris Biotherapeutics Sign Consent Agreement With FTC Staff 70
13.6 Product News 71
13.6.1 Oct 27, 2008: Grifols Presents BlisPack, An Automated Blister Identification And Opening Tool For Medications In The Hospital 71
14 Appendix 72
14.1 Research Methodology 73
14.2 Secondary Research 73
14.3 Primary Research 73
14.4 Models 74
14.5 Forecasts 74
14.6 Expert Panels 74
14.7 GlobalData Consulting 74
14.8 Currency Conversion 75
14.9 Contact Us 76
14.10 Disclaimer 76